Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15501 | 28874313 | Gastroenterol Hepatol | New therapeutic perspectives in non-alcoholic steatohepatitis. | 2017 | Details |
| A15504 | 28870674 | J Hepatol | Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study. | 2017 | Details |
| A15509 | 28868358 | AACE Clin Case Rep | GLYCOGENIC HEPATOPATHY: A COMPLICATION OF UNCONTROLLED DIABETES. | 2017 | Details |
| A15520 | 28864376 | Am J Med Sci | Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15523 | 28862712 | Int J Biol Markers | Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting. | 2017 | Details |
| A15525 | 28862262 | Mod Pathol | Centrilobular ductular reaction correlates with fibrosis stage and fibrosis progression in non-alcoholic steatohepatitis. | 2017 | Details |
| A15527 | 28860506 | Sci Rep | Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS. | 2017 | Details |
| A15530 | 28859228 | Hepatology | Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. | 2017 | Details |
| A15535 | 28857208 | Aliment Pharmacol Ther | Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. | 2017 | Details |
| A15539 | 28853202 | Liver Int | Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients. | 2017 | Details |
| A15542 | 28852205 | Int J Obes (Lond) | Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. | 2017 | Details |
| A15544 | 28850969 | Dtsch Med Wochenschr | [Statins as a Therapy of Chronic Liver Disease?] | 2017 | Details |
| A15552 | 28846948 | Int J Surg Case Rep | Biopsy-proven progressive fatty liver disease nine months post mini-gastric bypass surgery: A case study. | 2017 | Details |
| A15554 | 28845983 | J Med Chem | A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15558 | 28844958 | Biochim Biophys Acta Mol Basis Dis | Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet. | 2017 | Details |
| A15566 | 28840806 | Microbiol Spectr | Microbiota, Liver Diseases, and Alcohol. | 2017 | Details |
| A15567 | 28840697 | Zhongguo Zhong Yao Za Zhi | [Effect of Psoralea corylifolia in treating fatty liver disease in juvenal mouse by inhibiting hepatic NF-κB activation]. | 2017 | Details |
| A15577 | 28836404 | Cell J | Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats. | 2017 | Details |
| A15580 | 28833331 | Hepatology | A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. | 2018 | Details |
| A15585 | 28828531 | Abdom Radiol (NY) | Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors. | 2018 | Details |
| A15593 | 28823829 | Clin Gastroenterol Hepatol | Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis. | 2017 | Details |
| A15596 | 28823367 | Hepatobiliary Pancreat Dis Int | Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15600 | 28820447 | Int J Mol Sci | Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats. | 2017 | Details |
| A15601 | 28820393 | J Physiol Pharmacol | Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease. | 2017 | Details |
| A15606 | 28815679 | Clin Exp Pharmacol Physiol | (-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease. | 2017 | Details |
| A15613 | 28811064 | Ultrasound Med Biol | Evaluation of Non-alcoholic Fatty Liver Disease Using Acoustic Radiation Force Impulse Imaging Elastography in Rat Models. | 2017 | Details |
| A15618 | 28805669 | Nutrients | Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. | 2017 | Details |
| A15621 | 28804621 | Biomed Rep | Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease. | 2017 | Details |
| A15623 | 28803953 | J Hepatol | Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. | 2017 | Details |
| A15624 | 28803504 | Expert Rev Clin Pharmacol | The pharmacological management of NAFLD in children and adolescents. | 2017 | Details |
| A15625 | 28802640 | Clin Chim Acta | Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins. | 2017 | Details |
| A15628 | 28802074 | Hepatology | Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. | 2017 | Details |
| A15630 | 28800087 | Children (Basel) | Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents. | 2017 | Details |
| A15632 | 28799714 | Mol Nutr Food Res | Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15636 | 28796993 | Digestion | Oral Administration of CardioAid and Lunasin Alleviates Liver Damage in a High-Fat Diet Nonalcoholic Steatohepatitis Model. | 2017 | Details |
| A15638 | 28796410 | Liver Int | Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease. | 2017 | Details |
| A15643 | 28791501 | J Gastroenterol | Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease. | 2017 | Details |
| A15645 | 28790222 | Acta Med Indones | Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors. | 2017 | Details |
| A15649 | 28789631 | BMC Gastroenterol | Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. | 2017 | Details |
| A15650 | 28787358 | J Clin Gastroenterol | The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients. | 2018 | Details |
| A15655 | 28781602 | Nutr Metab (Lond) | eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet. | 2017 | Details |
| A15658 | 28777879 | Hepatology | Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. | 2017 | Details |
| A15659 | 28777871 | Hepatology | A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation. | 2017 | Details |
| A15672 | 28774869 | Am J Physiol Gastrointest Liver Physiol | Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis. | 2017 | Details |
| A15674 | 28772340 | J Viral Hepat | Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study. | 2017 | Details |
| A15681 | 28767077 | Children (Basel) | Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15689 | 28759632 | PLoS One | Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15693 | 28758097 | Ann Transl Med | Prognostic value of red blood cell distribution width in hepatocellular carcinoma. | 2017 | Details |
| A15700 | 28752524 | Aliment Pharmacol Ther | Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD. | 2017 | Details |
| A15707 | 28751080 | Med Clin (Barc) | Non-alcoholic fatty liver disease: A poorly known pandemic. | 2017 | Details |
| A15712 | 28749418 | Nutrients | The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2017 | Details |
| A15715 | 28747982 | Lab Anim Res | Comparative study of fatty liver induced by methionine and choline-deficiency in C57BL/6N mice originating from three different sources. | 2017 | Details |
| A15717 | 28745372 | Mol Biosyst | Systems-level organization of non-alcoholic fatty liver disease progression network. | 2017 | Details |
| A15721 | 28744823 | J Gastroenterol | Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A15725 | 28741298 | Hepatology | Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A15727 | 28741270 | J Gastroenterol | Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. | 2017 | Details |
| A15728 | 28741239 | Obes Surg | Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features. | 2018 | Details |
| A15735 | 28737569 | J Pediatr Gastroenterol Nutr | Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15740 | 28734086 | Acta Biochim Pol | The role of serum hyaluronic acid determination in the diagnosis of liver fibrosis. | 2017 | Details |
| A15745 | 28731143 | Mol Med Rep | Suppression of hepatic dysfunction in tenascin‑X‑deficient mice fed a high‑fat diet. | 2017 | Details |
| A15746 | 28730823 | Physiol Res | Pathophysiological analysis of the progression of hepatic lesions in STAM mice. | 2017 | Details |
| A15747 | 28730729 | Pediatr Obes | Traffic-related air pollution associations with cytokeratin-18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric population. | 2017 | Details |
| A15749 | 28730512 | Inflammation | NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid. | 2017 | Details |
| A15756 | 28726335 | J Gastroenterol Hepatol | Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes. | 2018 | Details |
| A15760 | 28723414 | Pharmacol Ther | Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease. | 2017 | Details |
| A15767 | 28720429 | Pharmacol Ther | Stable isotope-based flux studies in nonalcoholic fatty liver disease. | 2017 | Details |
| A15770 | 28718838 | Nutrients | Phyllanthus Niruri Standardized Extract Alleviates the Progression of Non-Alcoholic Fatty Liver Disease and Decreases Atherosclerotic Risk in Sprague-Dawley Rats. | 2017 | Details |
| A15774 | 28716600 | Clin Res Hepatol Gastroenterol | The utility of NAFLD fibrosis score for prediction of mortality among patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of cohort study. | 2017 | Details |
| A15777 | 28714405 | Curr Pharm Des | Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter. | 2017 | Details |
| A15780 | 28712339 | Expert Rev Gastroenterol Hepatol | The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2017 | Details |
| A15782 | 28711549 | J Clin Lipidol | A case of hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function mutation and polymorphisms predisposing to nonalcoholic fatty liver disease. | 2017 | Details |
| A15784 | 28710554 | Obes Surg | Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A15793 | 28706775 | Curr Hepatol Rep | Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much? | 2017 | Details |
| A15796 | 28705785 | Turk J Gastroenterol | Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis. | 2017 | Details |
| A15802 | 28702667 | Integr Biol (Camb) | Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development. | 2017 | Details |
| A15813 | 28696585 | Hepatology | The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. | 2017 | Details |
| A15815 | 28695813 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | Value of Acoustic Radiation Force Impulse Imaging in the Diagnosis of Early Non-alcoholic Steatohepatitis. | 2017 | Details |
| A15817 | 28695325 | Eur J Nutr | A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326. | 2017 | Details |
| A15818 | 28694658 | World J Gastroenterol | Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease. | 2017 | Details |
| A15820 | 28694246 | Eur J Endocrinol | MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. | 2017 | Details |
| A15822 | 28692443 | J Clin Gastroenterol | A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases. | 2017 | Details |
| A15835 | 28689548 | Ugeskr Laeger | [Non-alcoholic fatty liver disease in children and adolescents]. | 2017 | Details |
| A15840 | 28687459 | Drug Discov Today | Mouse models of nonalcoholic steatohepatitis in preclinical drug development. | 2017 | Details |
| A15844 | 28685692 | Curr Top Med Chem | Molecular Determinants of Chronic Liver Disease as Studied by NMR-Metabolomics. | 2017 | Details |
| A15847 | 28684781 | Sci Rep | Characterization of transcriptional modules related to fibrosing-NAFLD progression. | 2017 | Details |
| A15853 | 28680292 | Curr Oncol | Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases. | 2017 | Details |
| A15855 | 28679676 | BMJ Open | Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study. | 2017 | Details |
| A15856 | 28679028 | Liver Int | Hepatic iron is the major determinant of serum ferritin in NAFLD patients. | 2017 | Details |
| A15858 | 28678410 | NMR Biomed | Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis. | 2017 | Details |
| A15859 | 28678199 | Int J Mol Sci | The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. | 2017 | Details |
| A15862 | 28677333 | Aliment Pharmacol Ther | Review article: new treatments in non-alcoholic fatty liver disease. | 2017 | Details |
| A15865 | 28676973 | Eur J Nutr | Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats. | 2017 | Details |
| A15867 | 28676836 | Oxid Med Cell Longev | Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH. | 2017 | Details |
| A15875 | 28676020 | Curr Vasc Pharmacol | Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease. | 2018 | Details |
| A15876 | 28676019 | Curr Vasc Pharmacol | Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk. | 2018 | Details |
| A15877 | 28676018 | Curr Vasc Pharmacol | Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? | 2018 | Details |
| A15878 | 28674631 | Open Heart | Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. | 2017 | Details |
| A15879 | 28674415 | Sci Rep | MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. | 2017 | Details |
| A15882 | 28673684 | Toxicol Appl Pharmacol | The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis. | 2017 | Details |
| A15883 | 28673635 | J Pharmacol Sci | Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet. | 2017 | Details |